Treatment of Opioid Dependent Patients With Suboxone: Acceptability & Safety Data From Real Life Scenario (Study P05603)
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The aim of this post marketing surveillance study is to investigate the retention rate after
12 months of drug dependence treatment with SUBOXONE® (buprenorphine plus naloxone) of opioid
dependent patients under real life conditions.
Details
Lead Sponsor:
Indivior Inc.
Treatments:
Buprenorphine Buprenorphine, Naloxone Drug Combination Naloxone